Skip to main content
Caplight Logo









Adiso Therapeutics

Adiso Therapeutics

Private
Newton, MassachusettsHealthcare & Life Scienceshttps://adisotx.com/

Last Round

Series A

Mar 10, 2022

Total Funding Raised

$60M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Adiso Therapeutics is a biotechnology company that develops novel therapeutics to treat inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall molecule therapyinflammatory bowel diseaseIBDulcerative colitisneutrophil modulatorNLRP3 inhibitorclinical-stage biotechdrug pipelinebiotech startupclinical trialsdrug licensingtherapeutic developmentpharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adiso Therapeutics Comparables

Compare Adiso Therapeutics with similar companies based on industry and business-model similarity.

Adiso Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.
81%
Cibus Therapeutics
80%
Olatec Therapeutics
80%

Adiso Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 10, 2022

Adiso Therapeutics Investors

Notable investors and investment history

Adiso Therapeutics investors
InvestorRounds
Morningside VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 38% MoM.

  • May 20, 2026

    Grew 27% QoQ from 11 to 14 employees.

Adiso Therapeutics Filings

Explore SEC and related filing metadata, where available.

Adiso Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Adiso Therapeutics's valuation, stock price, and market status.

Is Adiso Therapeutics a public or private company?

Adiso Therapeutics is a private company.

What is the current stock price of Adiso Therapeutics?

Adiso Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Adiso Therapeutics worth (valuation)?

Valuation information for Adiso Therapeutics is not publicly available.

Can I buy Adiso Therapeutics stock?

Adiso Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Adiso Therapeutics's last funding round?

Adiso Therapeutics's most recent funding round was Series A on March 10, 2022.

Who are the main investors in Adiso Therapeutics?

Key investors in Adiso Therapeutics include Morningside Ventures.

Will Adiso Therapeutics IPO soon?

No public IPO plans have been announced for Adiso Therapeutics.

How can I track Adiso Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adiso Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewton, Massachusetts
Employee Range10
Year Founded2022
Last FundingMar 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?